Skip to the page

Data / Drug companies / Geri-Care Pharmaceuticals, Corp

Geri-Care Pharmaceuticals, Corp: 100 products in the FDA NDC directory, labeler code 57896

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Geri-Care Pharmaceuticals, Corp (labeler code 57896) lists 100 products in the FDA National Drug Code Directory, covering 51 finished drugs by generic name. By type: 100 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 1, 2026.

The request: Watch Geri-Care Pharmaceuticals, Corp (FDA labeler code 57896): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
57896
Products in commercial distribution
100
Packages
172
Finished drugs by generic name
51
Prescription products
0
Over the counter products
100
Flagged as original packager
95 of 95 products that carry the flag
Started marketing in the last 12 months
11
Products with a marketing end date set
5
Earliest marketing start
January 1, 1989
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs8585%
Generic drugs (ANDA)1515%

Products by type

TypeProductsShare
Over the counter drugs100100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet2222%
Liquid2222%
Suspension1010%
Tablet, film coated77%
Tablet, chewable66%
Ointment55%
Capsule, liquid filled44%
Gel33%
Cream33%
Patch33%
Tablet, coated33%
Solution/ drops22%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Childrens Acetaminophen57896-155Tablet, chewableOver the counter monograph drugsSeptember 1, 2026
Esomeprazole57896-740Capsule, delayed releaseGeneric drugs (ANDA)August 19, 2026
Mucus relief57896-718TabletOver the counter monograph drugsAugust 1, 2026
Lidocaine Pain Relief Patch57896-163PatchOver the counter monograph drugsMay 1, 2026
Lidocaine Pain Relief Patch57896-161PatchOver the counter monograph drugsMay 1, 2026
Magnesium Citrate57896-266LiquidOver the counter monograph drugsJanuary 1, 2026
Antacid and antigas57896-666LiquidOver the counter monograph drugsDecember 1, 2025
Antacid and antigas57896-662LiquidOver the counter monograph drugsDecember 1, 2025
Antacid and antigas57896-655LiquidOver the counter monograph drugsDecember 1, 2025
Geri Care Tussin CF Max57896-596LiquidOver the counter monograph drugsDecember 1, 2025
GeriCare Tussin DM Max57896-591LiquidOver the counter monograph drugsDecember 1, 2025
Ear Wax Removal Drops57896-339Solution/ dropsOver the counter monograph drugsSeptember 1, 2025
Cetirizine HCl57896-992Tablet, film coatedGeneric drugs (ANDA)April 24, 2025
Geri Care Medicated Pads57896-115PatchOver the counter monograph drugsFebruary 6, 2025
Extra Strength Acetaminophen57896-219TabletOver the counter monograph drugsNovember 1, 2024
Heartburn relief57896-565SuspensionOver the counter monograph drugsJuly 1, 2024
Geri-kot57896-434TabletOver the counter monograph drugsJuly 1, 2024
Extra Strength Night Time Pain Medicine57896-224TabletOver the counter monograph drugsJuly 1, 2024
Omeprazole57896-659Tablet, delayed releaseGeneric drugs (ANDA)May 23, 2024
MAXIMUM STRENGTH Antacid57896-664SuspensionOver the counter monograph drugsMay 1, 2024
Gentle Laxative57896-615LiquidOver the counter monograph drugsApril 1, 2024
Famotidine57896-319Tablet, film coatedGeneric drugs (ANDA)April 1, 2024
Famotidine57896-317Tablet, film coatedGeneric drugs (ANDA)March 1, 2024
Childrens Chewable Acetaminophen57896-148Tablet, chewableOver the counter monograph drugsFebruary 1, 2024
Stool Softener57896-411Capsule, liquid filledOver the counter monograph drugsJanuary 1, 2024

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.